{
    "title": "Biocon may list biosimilars business by 2025 first half - CEO",
    "url": "https://www.dailymail.co.uk/wires/reuters/article-12397711/Biocon-list-biosimilars-business-2025-half--CEO.html",
    "date": "2023-08-11",
    "keywords": [
        "biocon",
        "business",
        "revenue",
        "half",
        "biosimilar",
        "sadam",
        "ltd",
        "viatris",
        "market",
        "growth",
        "hyderabad",
        "company",
        "contributor",
        "companys",
        "executive",
        "subsidiary",
        "europe",
        "time",
        "ceo",
        "director",
        "siddharth",
        "year",
        "couple",
        "stage",
        "transition",
        "debt",
        "acquisition",
        "mittal",
        "costlier",
        "cancer",
        "rheumatoid",
        "arthritis",
        "psoriasis",
        "research",
        "firm",
        "value",
        "mckinsey",
        "industry",
        "drop",
        "profit",
        "performance",
        "quarter",
        "portfolio",
        "oncology",
        "immunology",
        "editing",
        "sohini",
        "goswami"
    ],
    "category": [
        "wires",
        "reuters"
    ]
}